The PGRN-Hub strives to make the Pharmacogenomics Research Network (PGRN) more effective for its members, and to that end is pleased to announce the inaugural PGRN-wide member call, to be held via web conferencing on Friday, April 7, 2017 at 11 am Pacific time / 1 pm Eastern time.
On this call, PGRN members will be provided with an overview of some of the resources provided by the PGRN-Hub to the pharmacogenomics research community, with a tour of some of the key features of our website. We will discuss the PGRN-RIKEN and BioBank Japan resources, and provide instructions on how to submit a proposal while also sharing tips from successful applicants.
In addition, there will be a discussion on PGRN Member Communities, in which PGRN members with similar interests could form interest groups and plan PGRN activities. Members will also be provided with an opportunity to provide feedback and comments on the PGRN during an open discussion session.
Not yet a member? Apply for PGRN membership today by clicking here.
The first CPIC Meeting was held in March at the ASCPT annual meeting!
Despite the winter weather in Washington D.C., the meeting was well attended by scientists and clinicians from academia, industry and government. This meeting brought together individuals who are passionate about translational science and implementation. Real-world strategies for implementing pharmacogenetics were described, for example the feasibility of CYP2C19 genotyping for clopidogrel response (by IGNITE Network) Successful implementation of actionable gene-drug pairs using genotype data was included in symposium (by PharmCAT). In contrast, speakers from two centers shared their tougher challenges for implementation, in particular, use of pharmacogenetics in different ethnic groups to guide dosing of warfarin and the use of CYP2D6 genotype for tamoxifen in breast cancer. In the final session of the meeting, four spectacular scientists shared their successes and challenges of pharmacogenetics implementation in different parts of the world, from Europe, to Asia and to Africa. The huge global effort in implementation of pharmacogenetics has been aided by the support of the local health care systems for a variety of essential medicines, such as anti-coagulant, anti-HIV and anti-epileptic drugs.
The Hub team